License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
Innovative compressor inlet invention which increases compressor flow range with use of an inlet duct that pre-swirls inlet flow of turbocharger compressor.
A novel fast warm forming method which improves the manufacturing productivity of high-strength metal sheet parts
A novel cooling technique to improve the speed and sensitivity of RF measurements. The technique allows quantum measurements to be performed with room-temperature equipment, as well as more sensitive and quicker EPR and NMR measurements.
A novel method to fabricate porous metal mats with high porosity, variable/controllable thicknesses, high surface area and good mechanical strength
A novel technique to manufacture Fibre Reinforced Plastic (FRP) with improved damage tolerance
An entirely new MRI system that exploits the 55° magic angle to provide useful image contrast and novel information about the collagen microstructure in ligaments, tendons and menisci.
A method for fine-tuning gene expression in Yarrowia Lipoltica
Improved process for synthesizing ammonia under ambient conditions significantly reducing energy requirements and carbon emissions.
Methods to tune the porosity of boron nitride and shape porous boron nitride into densified ready-to-use macrostructures
A novel nanomedicine platform technology using biocompatible and biodegradable nanovesicles as carriers for a variety of clot-lysing thrombolytics
Licensing and IP performance 2019/20
Imperial inventors submitted 250 invention disclosures to our IPC team during the year
Imperial College London's licensing portfolio comprises 244 licences
Imperial filed 137 patents (including PCT applications) during the year
Imperial's patent portfolio reached 331 patents during the year
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.